Evidence map›Paper›PMID 32970603›Full record

ArticleJMIR cancer2020

Correction: Incorporating Breast Cancer Recurrence Events Into Population-Based Cancer Registries Using Medical Claims: Cohort Study.

Teresa A'mar, J David Beatty, Catherine Fedorenko, Daniel Markowitz, Thomas Corey, Jane Lange, Stephen M Schwartz, Bin Huang, Jessica Chubak, Ruth Etzioni

Abstract readPublished Erratum
In one paragraph

Article in JMIR cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Teresa A'mar *Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-8634-1142
J David BeattySwedish Cancer Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-9693-6812
Catherine FedorenkoPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-6478-0769
Daniel MarkowitzSwedish Cancer Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-0841-844X
Thomas CoreyPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-3044-2072
Jane LangePublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-0014-9679
Stephen M SchwartzPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-7499-8502
Bin HuangCollege of Medicine, University of Kentucky, Lexington, KY, United States.ORCID https://orcid.org/0000-0002-9075-1531
Jessica Chubak *Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-1630-9021
Ruth Etzioni *Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-9164-6370

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
NCI NIH HHS P30 CA177558
6 · The paper itself

Abstract

[This corrects the article DOI: 10.2196/18143.].

Identifiers

PMID32970603
PMCPMC7545323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.